TY - JOUR
T1 - Key residues at third CDR3β position impact structure and antigen recognition of human invariant NK TCRs
AU - Chamoto, Kenji
AU - Guo, Tingxi
AU - Scally, Stephen W.
AU - Kagoya, Yuki
AU - Ancruzowski, Mark
AU - Wang, Chung Hsi
AU - Rahman, Muhammed A.
AU - Saso, Kayoko
AU - Butler, Marcus O.
AU - Chiu, Priscilla P.L.
AU - Julien, Jean Philippe
AU - Hirano, Naoto
N1 - Funding Information:
This work was supported by National Institutes of Health Grant R01 CA148673 (to N.H.), Ontario Institute for Cancer Research Clinical Investigator Award IA-039 (to N.H.), a BioCanRx catalyst grant (to N.H.), the Princess Margaret Cancer Foundation (to M.O.B. and N.H.), a Knudson postdoctoral fellowship (to K.C.), a Canadian Institutes of Health Research Canada graduate scholarship (to T.G.), the Province of Ontario (to T.G. and M.A.); and a Natural Sciences and Engineering Research Council of Canada postgraduate scholarship (to T.G.).
Publisher Copyright:
Copyright © 2017 by The American Association of Immunologists, Inc.
PY - 2017/2/1
Y1 - 2017/2/1
N2 - The human invariant NK (iNK) TCR is largely composed of the invariant TCR Vα24-Jα18 chain and semivariant TCR Vβ11 chains with variable CDR3β sequences. The direct role of CDR3β in Ag recognition has been studied extensively. Although it was noted that CDR3β can interact with CDR3α, how this interaction might indirectly influence Ag recognition is not fully elucidated. We observed that the third position of Vβ11 CDR3 can encode an Arg or Ser residue as a result of somatic rearrangement. Clonotypic analysis of the two iNK TCR types with a single amino acid substitution revealed that the staining intensity by anti-Vα24 Abs depends on whether Ser or Arg is encoded. When stained with an anti-Vα24-Jα18 Ab, human primary invariant NKT cells could be divided into Vα24 low- and high-intensity subsets, and Arg-encoding TCR Vβ11 chains were more frequently isolated from the Vα24 low-intensity subpopulation compared with the Vα24 high-intensity subpopulation. The Arg/Ser substitution also influenced Ag recognition as determined by CD1d multimer staining and CD1d-restricted functional responses. Importantly, in silico modeling validated that this Ser-to-Arg mutation could alter the structure of the CDR3β loop, as well as the CDR3α loop. Collectively, these results indicate that the Arg/Ser encoded at the third CDR3β residue can effectively modulate the overall structure of, and Ag recognition by, human iNK TCRs.
AB - The human invariant NK (iNK) TCR is largely composed of the invariant TCR Vα24-Jα18 chain and semivariant TCR Vβ11 chains with variable CDR3β sequences. The direct role of CDR3β in Ag recognition has been studied extensively. Although it was noted that CDR3β can interact with CDR3α, how this interaction might indirectly influence Ag recognition is not fully elucidated. We observed that the third position of Vβ11 CDR3 can encode an Arg or Ser residue as a result of somatic rearrangement. Clonotypic analysis of the two iNK TCR types with a single amino acid substitution revealed that the staining intensity by anti-Vα24 Abs depends on whether Ser or Arg is encoded. When stained with an anti-Vα24-Jα18 Ab, human primary invariant NKT cells could be divided into Vα24 low- and high-intensity subsets, and Arg-encoding TCR Vβ11 chains were more frequently isolated from the Vα24 low-intensity subpopulation compared with the Vα24 high-intensity subpopulation. The Arg/Ser substitution also influenced Ag recognition as determined by CD1d multimer staining and CD1d-restricted functional responses. Importantly, in silico modeling validated that this Ser-to-Arg mutation could alter the structure of the CDR3β loop, as well as the CDR3α loop. Collectively, these results indicate that the Arg/Ser encoded at the third CDR3β residue can effectively modulate the overall structure of, and Ag recognition by, human iNK TCRs.
UR - http://www.scopus.com/inward/record.url?scp=85014716040&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85014716040&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.1601556
DO - 10.4049/jimmunol.1601556
M3 - Article
C2 - 28003379
AN - SCOPUS:85014716040
SN - 0022-1767
VL - 198
SP - 1056
EP - 1065
JO - Journal of Immunology
JF - Journal of Immunology
IS - 3
ER -